Stereoselective synthesis, X-ray analysis, computational studies and biological evaluation of new thiazole derivatives as potential anticancer agents. 2018

Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
Department of Chemistry, College of Science, King Saud University, P. O. Box 2455, Riyadh, 11451, Saudi Arabia. yahia@ksu.edu.sa.

BACKGROUND The synthesis of new thiazole derivatives is very important because of their diverse biological activities. Also , many drugs containing thiazole ring in their skeletons are available in the market such as Abafungin, Acotiamide, Alagebrium, Amiphenazole, Brecanavir, Carumonam, Cefepime, and Cefmatilen. RESULTS Ethyl cyanoacetate reacted with phenylisothiocyanate, chloroacetone, in two different basic mediums to afford the thiazole derivative 6, which reacted with dimethylformamide- dimethyl acetal in the presence of DMF to afford the unexpected thiazole derivative 11. The structures of the thiazoles 6 and 11 were optimized using B3LYP/6-31G(d,p) method. The experimentally and theoretically geometric parameters agreed very well. Also, the natural charges at the different atomic sites were predicted. HOMO and LUMO demands were discussed. The anticancer activity of the prepared compounds was evaluated and showed moderate activity. CONCLUSIONS Synthesis of novel thiazole derivatives was done. The structure was established using X-ray and spectral analysis. Optimized molecular structures at the B3LYP/6-31G(d,p) level were investigated. Thiazole derivative 11 has more electropositive S-atom than thiazole 6. The HOMO-LUMO energy gap is lower in the former compared to the latter. The synthesized compounds showed moderate anticancer activity.

UI MeSH Term Description Entries

Related Publications

Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
June 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
January 2016, European journal of medicinal chemistry,
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
July 2008, Archiv der Pharmazie,
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
November 2022, BMC chemistry,
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
April 2020, Future medicinal chemistry,
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
May 2023, ACS omega,
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
January 2012, PloS one,
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
September 2021, Molecules (Basel, Switzerland),
Yahia N Mabkhot, and Mohammed M Alharbi, and Salim S Al-Showiman, and Hazem A Ghabbour, and Nabila A Kheder, and Saied M Soliman, and Wolfgang Frey
October 2014, European journal of medicinal chemistry,
Copied contents to your clipboard!